Recalibrating the Pharmaceutical Services Opportunity
INTERPHEX 2013: Global bio/pharmaceutical companies are replacing their low-percentage strategy of “maximizing shots on goal” with more rigorous criteria for graduating candidates into the development pipeline. While they’ve become more selective, early stage companies have faced more challenges gaining financing. The combined effect of these two trends has been to reduce the number of candidates coming through the pipeline and tilt the game more in favor of larger bio/pharma companies. These new dynamics have serious implications for contract service providers. Only a relative handful will qualify to work with the largest bio/pharma companies, and those that don’t win preferred provider status will be fighting over a smaller market. Download these slides from Jim Miller’s INTERPHEX 2013 presentation for insight into the implications for contract service providers.
Industry Update and A Look Ahead to 2013
PharmSource’s Jim Miller presented an industry update at an AAPS 2012 breakfast co-sponsored by Pharmaceutical Technology magazine. Based on several trends measured since H1 2011, he noted that overall contract service industry performance is robust, though less so in early stage revenue growth. Citing higher R&D and service spends, as well as cash fund growth fueled by partnering, a positive path to bio/pharma’s future seems evident. To get the full picture on how acquisitions are reconfiguring the CMC market, how weak VC funding may threaten smaller CROs and CMOs, new players entering contract services and more, click on the link below to access the slides from this presentation.
Are CMOs Winning the War Against In-House Capacity?
At Contract Pharma’s 2012 Contracting and Outsourcing Conference, PharmSource’s Jim Miller addressed the direct impacts of manufacturing on the bio/pharma business model. His analysis focused on the key issues CMOs must face to gain a compelling foothold against captive capacity. His presentation provided important insights in understanding the supply chain context; the likely negative consequences of failing to differentiate operating skills; how CMOs can reduce risk and add value; and much more.
What the New Bio/Pharma Business Model Means for CMOs and CROs
In his keynote presentation at INTERPHEX 2012, Jim Miller, President of PharmSource, addressed the transformation of today’s bio/pharma business model, and the opportunities and challenges it presents to providers of development and manufacturing services. The presentation was sponsored by Pharmaceutical Technology magazine.
How Real is the Recovery in Contract Services?
At INTERPHEX 2011, PharmSource’s President, Jim Miller, made an incisive presentation addressing the issue of how real the recovery in contract services is. In this session, which was co-sponsored by PharmSource and Pharmaceutical Technology magazine, Jim talked about the impact of recent events on the supply chain, diverging paths in India and China, integrated models for early development, and much more.
Pharma Outsourcing Roundtable
At the Via Connect Pharma Outsourcing Roundtable in Paris in October 2010, PharmSource’s President, Jim Miller, moderated a panel discussing new approaches and business models to address supply chain challenges. Click on the link below to watch the videocast, which includes esteemed panelists from Pfizer, GSK, Bayer Healthcare and other senior Pharma executives exchanging insights and experiences. This event was hosted by iCSE.
Contract Services Make a Comeback?
Jim Miller, President of PharmSource, made a noteworthy presentation at the 2010 annual AAPS breakfast, which was co-hosted by PharmSource and Pharmaceutical Technology on November 15, 2010 in New Orleans, LA, USA. Click on the link below to access Jim’s slides and get his perspective on the gradual and choppy recovery of the contract services industry, and how factors like supply base consolidation and the intensely competitive climate are likely to play into things.
How Outsourcing Can Accelerate Early CMC Development
At BIO 2010, Jim Miller, president of PharmSource, interviewed Susan Dana Jones, PhD, vice president and senior consultant of BioProcess Technology Consultants, a provider of strategic and regulatory consulting services to the biopharmaceutical industry. The two industry experts discussed pharmaceutical outsourcing practices. The interview was sponsored by BioPharm International magazine.
State of the Pharmaceutical Outsourcing Industry 2010
At INTERPHEX 2010, in a session co-sponsored by PharmSource and Pharmaceutical Technology magazine, PharmSource president Jim Miller gave a much anticipated “State of the Contract Services Industry” presentation, where he reviewed the state of the market for contract services and issues facing service providers.
The Outlook for Contract Services: Is That Light at the End of the Tunnel?
On November 9, 2009, Jim Miller made a presentation entitled “The Outlook for Contract Services:Is That Light at the End of the Tunnel?” at a breakfast meeting sponsored by Pharmaceutical Technology magazine, where he discussed current market conditions and prospects for 2010.
State of the Pharmaceutical Outsourcing Industry 2009
At the 2009 Interphex Conference and Exhibition, Jim Miller delivered his Spring update on the state of the pharmaceutical outsourcing industry. Jim described the downturn in R&D spending in the pharmaceutical industry, the reasons for the downturn and the consolidation of the CRO and CMO industries that will be the lasting implication.
At the 2008 AAPS annual convention in Atlanta, GA, Jim Miller, president of PharmSource, moderated a panel exploring the challenges and benefits of outsourcing pharmaceutical research and development and manufacturing to Asia. The videocast event was sponsored by Pharmaceutical Technology magazine. Two esteemed panelists participated: Timothy Tyson, executive chairman and acting CEO at Aptuit and Dr. Wouter Huizinga, senior director, sales and business development at Dr. Reddy’s Custom Pharma Services.
CMOs and CROs as Business Solutions Providers:
A New Strategy for Contract Services Providers
At Jim Miller’s annual breakfast presentation at the 2008 AAPS Annual meeting, sponsored by Pharmaceutical Technology magazine, he discussed how the pharma industry’s changing business environment creates new opportunities for contract services providers. Read about the new business model Jim proposes, where CMOs and CROs move from being providers of capacity and technical expertise to providers of business solutions that address the wider strategic and financial concerns of their clients.
The Evolving CMC Development Business
In this presentation at a Pacific Region Clinical Supplies (PARCS) meeting, Jim Miller provided his insights into the evolving CMC development business. His CMC market overview, including a discussion of business models and challenges, is available in this download. Learn about this $5 billion market, and the related risk factors and opportunities in the current environment.
Trends in Pharma Outsourcing
In this two-part podcast, Michelle Hoffman, editor of Pharmaceutical Technology magazine, interviews PharmSource’s president, Jim Miller. In the first podcast, Jim talks about the current state of the pharmaceutical outsourcing industry. In the second podcast, he discusses strategic recommendations to contract service providers, including the relevance to CMOs and CROs of revising their business models to differentiate themselves in order to successfully face overcapacity.
State of the Pharmaceutical Outsourcing Industry 2008
Jim Miller addressed the “State of the Pharmaceutical Outsourcing Industry 2008″ in this presentation prepared for the Interphex conference in March 2008. The presentation described recent trends and performance in the contract manufacturing and research industry, and argued that the contract manufacturing sector is crying out for new business models. The slides and presentation notes can be downloaded here.
How Long Will the Good Times Roll?
On November 12, 2007, Jim Miller made a presentation entitled “How Long Will the Good Times Roll?” at a breakfast meeting sponsored by Pharmaceutical Technology magazine, where he discussed current market conditions and prospects for 2008.
State of the Pharmaceutical Outsourcing Industry 2007
Jim Miller, president of PharmSource and publisher of Bio/Pharmaceutical Outsourcing Report, made a presentation on industry conditions and trends on April 24, 2007, at the Interphex trade show in New York City.
State of the Contract Dose Manufacturing Business
Jim Miller, president of PharmSource, reviewed trends in the contract dose manufacturing industry at the BioPharMos conference in March 2007 in Monaco.
Incorporating Risk Management into the Outsourcing Relationship
Jim Miller, president of PharmSource, presented a framework for risk management in outsourcing at a January 2007 conference sponsored by DCAT.